ResMed (RMD) Reports In-Line Q4 EPS
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $210.98 +1.16%
EPS Growth %: +13.3%
Financial Fact:
Income taxes (note 13): 16.82M
Today's EPS Names:
HFBL, PBHC, PBNK, More
EPS Growth %: +13.3%
Financial Fact:
Income taxes (note 13): 16.82M
Today's EPS Names:
HFBL, PBHC, PBNK, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q4 EPS of $2.08, in-line with the analyst estimate of $2.08. Revenue for the quarter came in at $1.22 billion versus the consensus estimate of $1.22 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Regency Centers (REG) Tops Q2 EPS by 2c
- Madrigal Pharma (MDGL) Tops Q2 EPS by 76c
- Bogota Financial Corp. (BSBK) Reports Q2 EPS of $0.06
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
